ERVW-1 and viral infectious disease: In addition to the ability of VC2 to replicate well in nonneuronal cells, it may be that the alteration of initial host-pathogen interactions due to the mutations in HSV-1 envelope proteins gK and UL20 in VC2 lead to differential host responses that are more immunogenic than during wild-type virus infection.